86
Participants
Start Date
August 16, 2021
Primary Completion Date
October 30, 2023
Study Completion Date
October 30, 2023
Multispecies-Probiotic
Participants in intervention group receive 2x3g of a multistrain probiotic containing Bifidobacterium bifidum W23, Bifidobacterium lactis W51, Bifidobacterium lactis W52, Lactobacillus acidophilus W22, Lactobacillus casei W56, Lactobacillus paracasei W20, Lactobacillus plantarum W62, Lactobacillus salivarius W24, Lactococcus lactis W19.
Placebo Supplement
Participants in the placebo group receive 2x3 gram of a placebo supplement not containing probiotic strains.
Medical University of Graz, Graz
Collaborators (1)
Allergosan
UNKNOWN
Medical University of Graz
OTHER